Reversão da Anticoagulação
Neutralização do efeito anticoagulante
Pesquisar
Código de Conduta
Code of Conduct
Aftopor®/Aftovaxpur®/Aftovax®/Aftobov®Oleosa/Aftovaxpur®Doe
FMD vaccines with highly potent and purified antigens (Aftopor®, Aftovaxpur®, Aftobov® Oleosa) allow differentiation between infected and vaccinated animals for endemic or emergency situations.
BIO International 2022
BIO International 2022: Find out more about partnering with us!
Produtos para a Saúde Humana
Products Overview of our products.
EFPIA disclosure
Disclosure of Boehringer Ingelheim affiliates in countries with EFPIA member associations and disclosures of transfers of value (ToVs) to HCPs and HCOs.
TVP/EP
TVP/EP
Speak up!
Compliance – Speak up!
Tratamentos
We provide a disciplined scientific approach to the global discovery, development and delivery of therapeutics for all relevant animal species.
Parasiticidas
Read about Boehringer Ingelheim's Global Innovation and expertise in parasiticides for companion animals and cattle such as cats, dogs or horses.
Vacinas
Na Global Innovation, trabalhamos em vacinas seguras e eficazes para animais de companhia e gado. Reunimos uma vasta experiência em vacinologia, biologia molecular, bioprocessos, ensaios e desenvolvimento clínico.
Perturbação Estado-Limite da Personalidade
Borderline Personality Disorder
Foco no Doente
Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives.
EHNA
Learn more about the metabolic disease known as non-alcoholic steatohepatitis (NASH) by clicking here and visiting Boehringer Ingelheim.
Obesidade
Learn about obesity & see what Boehringer Ingelheim is doing to develop new medications to improve patients lives. Read the latest obesity articles here.
Hipertensão
Effective treatment and management of hypertension are important in order to avoid further complications or risks like heart attack or stroke.
Presença global
Sites Around the World
Depressão
Depression
Material de Imprensa
Find the latest press releases from Boehringer Ingelheim on animal health or access our media pool to view BI corporate news.
Sobre nós
A Boehringer Ingelheim é um grupo de empresas global, envolvendo diversas culturas e sociedades. Saiba mais sobre os destaques financeiros
COVID-19
COVID-19
Capacitação dos doentes
Dealing with cancer can be difficult for all concerned. Here we have provided numerous resources of dedicated advice provided by patients, for patients.
DPOC e Asma
Key goals of COPD management are to limit symptoms, reduce the risk of exacerbations and support people to live more active lives.
Cancro do Pulmão
Boehringer Ingelheim provides innovative lung cancer treatments with specialist products for 1st and 2nd line non-small-cell lung cancer (NSCLC)
O Processo de Investigação
A key part of our mission is to discover or identify new compounds, vaccines, technologies, disease processes, and infectious agents.